Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

RET Gene Mutation clinical trials

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

RET Gene Mutation: 1 US clinical trial tracked, none currently recruiting.

RET Gene Mutation is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is University of Virginia, running 1 of these trials.

Enrollment posture brief

Registry condition ret-gene-mutation

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%RET Gene Mutation (this)0%
Open-enrollment share among volume-matched conditions near RET Gene Mutation

RET Gene Mutation has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for RET Gene Mutation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. RET Gene Mutation is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on RET Gene Mutation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Fitbit Sense Device
1 trials
RX Cap Device
1 trials
Sensus Smartwatch Application Other
1 trials
Surveys Other
1 trials

US sites by state

Facility locations filed on RET Gene Mutation trials. A trial with sites in several states counts in each.

Virginia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this RET Gene Mutation page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No RET Gene Mutation trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • University of Virginia sponsors the most RET Gene Mutation trials on record, review their full trial history before evaluating a specific study. See University of Virginia's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This RET Gene Mutation condition card totals 1 registered trials; most-linked intervention Fitbit Sense; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.